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Natural indicators provide intrinsic probes of metabolism, biogenesis and oxidative
protection. Nicotinamide adenine dinucleotide metabolites (NAD(P)) are one class of
indicators that have roles as co-factors in oxidative phosphorylation, glycolysis, and
anti-oxidant protection, as well as signaling in the mitochondrial biogenesis pathway.
Thesemany roles are made possible by the distinct redox states (NAD(P)+ and NAD(P)H),
which are compartmentalized between cytosol and mitochondria. Here we provide
evidence for detection of NAD(P)+ and NAD(P)H in separate mitochondrial and cytosol
pools in vivo in human tissue by phosphorus magnetic resonance spectroscopy (31P
MRS). These NAD(P) pools are identified by chemical standards (NAD+, NADP+, and
NADH) and by physiological tests. A unique resonance reflecting mitochondrial NAD(P)H
is revealed by the changes elicited by elevation of mitochondrial oxidation. The decline
of NAD(P)H with oxidation is matched by a stoichiometric rise in the NAD(P)+ peak.
This unique resonance also provides a measure of the improvement in mitochondrial
oxidation that parallels the greater phosphorylation found after exercise training in these
elderly subjects. The implication is that the dynamics of the mitochondrial NAD(P)H peak
provides an intrinsic probe of the reversal of mitochondrial dysfunction in elderly muscle.
Thus, non-invasive detection of NAD(P)+ and NAD(P)H in cytosol vs. mitochondria
yields natural indicators of redox compartmentalization and sensitive intrinsic probes
of the improvement of mitochondrial function with an intervention in human tissues
in vivo. These natural indicators hold the promise of providing mechanistic insight into
metabolism and mitochondrial function in vivo in a range of tissues in health, disease
and with treatment.
Keywords: magnetic resonance spectroscopy, 31P MRS, nicotinamide adenine dinucleotide, NAD+, NADP+,
muscle, exercise
INTRODUCTION
Nicotinamide adenine dinucleotide is a co-enzyme that is integral to cell and mitochondrial
metabolism (Williamson et al., 1967; Stubbs et al., 1972; Nicholls and Ferguson, 2002; Ying,
2008; White and Schenk, 2012) and has a signaling role in mitochondrial biogenesis (Imai, 2011;
Canto and Auwerx, 2012). NADH is a key player in oxidative phosphorylation in mitochondria
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(Nicholls and Ferguson, 2002) and in glycolysis (Williamson
et al., 1967; Stubbs et al., 1972), while the related metabolite,
NADP, is important in anti-oxidant protection (Ying, 2008).
Optical methods detect the sum of these compounds (NAD+
and NADP+ = NAD(P)+) and can resolve their cellular location
to provide natural indicators of mitochondrial function and
cytosolic redox state (NAD(P)H/NAD(P)+) (Jobsis and Duffield,
1967; Barlow and Chance, 1976; Wendt and Chapman, 1976;
Scholz et al., 1995; Mayevsky and Rogatsky, 2007; Gandra et al.,
2012; Claflin et al., 2015). These measures have lead to insight
into the role of NAD(P) redox in oxidative stress (Ying, 2008;
Murphy, 2009; Aon et al., 2010; Massudi et al., 2012a), as an index
of oxygenation states (Barlow and Chance, 1976; Mayevsky and
Rogatsky, 2007), and as a probe of mitochondrial (dys)function
in age and disease (Heikal, 2010; Massudi et al., 2012b; Claflin
et al., 2015). However, optical measures are typically limited to
isolated tissues and are limited in depth penetration in vivo. A
non-invasive measure of NAD(P) in vivo would open a window
on cell and mitochondrial metabolism in age and disease as well
as the impact of treatments to reverse metabolic dysfunction.
Non-invasive magnetic resonance methods now make
detecting NAD(P)+ and NAD(P)H in vivo possible both in
animals and humans (de Graaf and Behar, 2014; Zhu et al.,
2015). A distinct spectral position (chemical shift, CS) in the
phosphorus spectrum (31P MRS) is found for each metabolite
representing the NAD(P)+ and NAD(P)H redox states (Lu
et al., 2014). It may also be possible to distinguish the cellular
location of these NAD(P) redox states since several metabolites
are reported to show distinct CS in the 31P MR spectrum
between these two compartments (Garlick et al., 1983; Hutson
et al., 1989, 1992). For example, both ATP and NADP+ show
striking differences in CS with Mg2+ binding at the low metal
concentration in the cytosol vs. the 10-fold higher level found
in mitochondria (Mas and Colman, 1984; Gout et al., 2014).
Inorganic phosphate also shows a significant chemical shift
in vivo as a result of the pH difference in cytosol vs. mitochondria
(Garlick et al., 1983; Hutson et al., 1992; Kan et al., 2010). There
are also promising studies suggesting that NAD(P) redox states
can be distinguished between the mitochondria vs. the cytosol.
These studies found that phosphoryl compounds related to
NAD(P) showed CS differences between erythrocytes vs. the
bathing solution that are large enough to be detected by 31P
MRS (Kirk and Kuchel, 1988a,c). Thus, it may be possible to
detect a NAD(P)H CS difference inside mitochondria relative to
the cytosol in the 31P MR spectrum thereby providing a natural
indicator of key player in oxidative phosphorylation.
Here we describe a unique resonance in the 31P MRS
spectrum that conforms with the properties of NAD(P)H in
mitochondria in human muscle in vivo. The aim of this study
was to test the nature of this new resonance and determine
if it provides a natural indicator of mitochondrial oxidative
function. The first test compared this unique resonance to
chemical standards of metabolites known to be present in the
same region of the 31PMR spectrum, including NAD+, NADP+,
NADH, and NADPH (Kushmerick et al., 1986). No overlap in
the spectral position (chemical shift) of the unique resonance
vs. that of known metabolites was found. Two additional tests
were performed to determine whether dynamics elicited in
this peak by exercise conformed with changes expected for
mitochondrial NAD(P)H. This functional test was designed
to elevate oxidative phosphorylation and involved 40 elderly
subjects before and after exercise training. The pre-training
test revealed a reciprocal decline in the unique resonance
vs. elevation in NAD(P)+, which are changes consistent with
oxidation of mitochondrial NAD(P)H to NAD(P)+. The post-
training test found a greater change in the unique resonance
after exercise training, which is consistent with elevated oxidation
and the greater phosphorylation rate reported in these subjects.
Taken together, these results provide evidence that this MRS
detectable resonance conforms to the properties ofmitochondrial
NAD(P)H. Thus, this unique resonance holds promise as
the first natural indicator of the inner workings of oxidative
phosphorylation in the 31P MRS spectrum. It also holds promise
as a sensitive indicator of the mitochondrial response to
treatments designed to improve mitochondrial function.
METHODS
Subjects
An elderly group consisted of 40 subjects (18 male, 22 female)
ranging in age from 65 to 80 years (68.8 ± 5.9 years, means ±
S.E.M.). Subjects were not involved in formal exercise training,
were in good health and had no significant cardiac, neurological,
or musculoskeletal disease, as we have described (Conley et al.,
2000; Jubrias et al., 2001). All subjects voluntarily gave informed,
written consent as approved by the University of Washington
Human Subjects Review Committee and in accordance with the
Declaration of Helsinki.
MR Methods
A General Electric 1.5 T Signa imager/spectrometer was used
for the in vivo spectra as described (Conley et al., 2000). A
9 cm diameter surface coil tuned to the phosphorus frequency
(25·9MHz) was placed over the vastus lateralis muscle of the
thigh. The B1 field homogeneity was optimized by off resonance
proton shimming on the muscle water peak. The unfiltered
PCr linewidth (full width at half-maximal height) was typically
4–8. Each subject had a high resolution 31P MR spectrum of
the resting vastus lateralis muscle taken under conditions of
fully relaxed nuclear spins (16 free-induction decays (FID) with
a 16 s interpulse delay) using a spectral width of ±1250Hz
and 2048 data points. Since volume selective methods were
not used in collection, the spectra represent signal from a
hemispherical volume defined by the coil radius. No volume
selective methods were used to collect the spectra. Dynamic
changes during stimulation and recovery were made using a
standard 1-pulse experiment with partially saturated nuclear
spins (1.5 s interpulse delay). Artifacts due to movement were
reduced by stabilizing the limb during the muscle contractions.
All fully relaxed spectra were zero filled from 2048 to 4096
points, Fourier transformed with 15Hz apodization, baseline
corrected, and manually phased using the Mnova software
package (Mestrelab Research, Santiago de Compostela (Spain)).
No other spectral treatment was employed.
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Chemical Phantoms
Metabolites that resonate in the NAD(P) region of the 31P
MR spectrum were identified from muscle extracts (Kushmerick
et al., 1986). Solutions containing these chemicals were prepared
using binding constants taken from the USA National Institute
of Standards and Technology (NIST) Critically Selected Stability
Constants of Metal Complexes Database (see Kushmerick, 1997).
All solutions contained (in mmol/L): EGTA 15, MOPS 80, free
Mg2+ 1, Na+ 83, and K+ 52. The following were varied in
individual solutions: ATP, ADP, Pi, Creatine Phosphate (PCr),
ADP, NAD+, NADH, NADP+, or UDP-Glucose. The ionic
strength was maintained at 0.175M, pH = 7.0 (36◦C) in all
solutions. High-resolution MR spectra of individual solutions in
an NMR tube were taken at 4.7T (sweep width= 10,000Hz, 16 K
complex points, 128 FIDs, 5 s delay between pulses).
Peak Simulations
Resonances were simulated at 1.5T using the spin parameters
and chemical shifts for the simulations determined from NAD+,
NADP+, and NADH in physiological solution at 4.7T. The Spin
Simulation feature of the Mnova software (Mestrelab Research,
Santiago de Compostela (Spain)) permitted determining the
spectral properties of these resonances. The line-width of the
simulated resonances were fixed to that of α-ATP due to the
similar chemical environment of the two phosphate groups in
NAD(P). The details of this process have been described (Lu et al.,
2014).
NAD(P) Region In vivo
The −10.4 to −11.3 region containing NAD+ and NADP+ was
extracted from the fully relaxed spectra by fitting a Lorenzian
line shape to the α–ATP peak (Figure 1). The spectral intensity
of this region was integrated as well as three sub-regions:
−10.5 to −10.68 ppm (NADH), −10.69 to −10.92 (NAD(P)+)
and −10.93 to −11.30 (hereafter, −11.05 ppm). The dynamic
changes in these regions were determined by subtraction spectra
normalized to the α–ATP level between stimulated vs. resting
muscle and during recovery vs. resting muscle.
Stimulation and Recovery Protocol
The quadriceps muscles were activated by transcutaneous
electrical stimulation of the femoral nerve, as previously
described (Blei et al., 1993; Conley et al., 2000). Spectra were
collected during rest, stimulation and recovery to measure the
PCr, Pi, ATP, and the NAD(P) region peaks. Spectra were
averaged during each of the three periods to analyze the NAD(P)
region peaks:
Control period (60 s, 10 spectra): Baseline data were obtained
during resting muscle conditions to establish initial metabolite
peak levels.
Stimulation period (120 s, 20 spectra): A 3Hz electrical
stimulation period was used to decrease [PCr] and activate
NAD(P)H synthesis.
Aerobic recovery (300 s, 50 spectra): upon cessation of
stimulation, PCr recovery was followed until restoration
of baseline levels during which NAD(P)H oxidation was
determined.
Statistics
Pre- vs. post-training differences relative to zero were tested
with a 2-tailed Student’s t-test. No adjustment for multiple
comparisons was made as per reference (Perneger, 1998).
Statistical differences are reported at P < 0.05. Means are
reported±SEM.
RESULTS
Here we show evidence for a unique resonance in the 31P
spectrum corresponding to NAD(P)H in mitochondria. To
identify this resonance, we first compare the unique resonance
against known metabolites in muscle. Second, we test the link
between the unique resonance vs. the change in mitochondrial
content that came with exercise training in these subjects.
Third, we use an acute exercise bout to activate NAD(P)H
oxidation to test for changes in the resonance and determine
whether these changes (oxidation) parallel the improvement in
phosphorylation found after exercise training in these subjects.
Unique Resonance in 31P Spectrum In vivo
The presence of an unidentified peak in the 31P MR spectrum
of human muscle is illustrated in Figure 1. An expansion of
the spectrum in the α–ATP region shows the NAD(P) peak
region from −10.4 to −11.3 ppm. This spectrum was taken
from an elderly vastus lateralis muscle under MR conditions in
which peak areas reflect their chemical content (i.e., fully relaxed
conditions). The resonances for chemical standards of NADH
(−10.6 ppm), NAD+ (−10.75 ppm), and NADP+ (−10.84 ppm)
are superimposed on the NAD region from the in vivo spectrum
in Panel B [UDP-glucose is also present (Kushmerick et al.,
1986) and resonates in this region at −10.84 in in vitro solutions
that emulate in vivo conditions]. This comparison highlights the
presence of an additional resonance centered at −11.05 ppm in
the NAD(P) region. Thus, the unique resonance at −11.05 ppm
does not correspond with resonances for metabolites in this
spectral region that have been identified in tissue extracts
(Kushmerick et al., 1986).
Unique Resonance is 40% of Total NAD(P)
Integral
The NAD(P) integral is 11% of the area of α–ATP (11.5± 1.0%),
which agrees with the total NAD per ATP content (7–
12%; Sahlin, 1983; Henriksson et al., 1986) reported from
biochemical analyses in human vastus lateralis muscle (Sahlin,
1983; Henriksson et al., 1986; Ren et al., 1988). Based on the
ATP level in these muscles (5.8mM; Conley et al., 2000), the full
integral (0.7mM) contains 0.4mMNAD(P) (60% of the integral)
vs. 0.5mMmeasured for total NAD in youngmuscle (Henriksson
et al., 1986). The unique resonance at −11.05 ppm is the second
largest peak in the NAD(P) integral (Figure 1C), which translates
to 0.25mM (38% of the total). This is close to the value (0.26mM)
estimated from the NADH content of muscle mitochondria
(heart, 10 nmole/mg mitochondrial protein, Alano et al., 2007)
and the mitochondrial volume density of the elderly muscle in
this study [3% (Conley et al., 2000), i.e., 10 nmole/mg ×mg
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FIGURE 1 | NAD(P) resonances in vivo in human muscle. (A) 31P magnetic resonance spectrum from human vastus lateralis at 1.5T with expansion of α–ATP
and NAD(P). (B) Resonances for NADH, NAD+, and NADP+ (dashed lines) vs. the in vivo spectrum (blue) reveal an unidentified peak (arrow, −11.05 ppm). (C)
Content of the three resonances in vivo [NAD(P)] per ATP content, mean % ± SEM, n = 39 (Conley et al., 2000).
protein/µl (Vinnakota and Bassingthwaighte, 2004) × 0.03µl
mito/µl muscle = 0.26 nmole/µl or 0.26mM]. Thus, two key
segments of the NAD(P) region in vivo are consistent in size
with the contents of total NAD+ assayed in muscle and NADH
estimated from mitochondrial volume density of human muscle.
In contrast, the small resonance at −10.6 ppm associated
with NADH in solution was 5% of the total integral in the
NAD(P) region or ∼0.01mM. A low NADH content in the
cell is expected from the oxidized NAD redox state maintained
by enzyme equilibria linked to the phosphorylation potential
(Williamson et al., 1967; Stubbs et al., 1972). This low value agrees
with the NADH levels in older bioluminescent assays on human
vastus lateralis tissue (0.02mM at rest, Henriksson et al., 1986).
These findings suggest that the chemical standard for NADH
at −10.6 ppm identifies the resonance for the small cellular
NADH pool, while the larger −11.05 ppm resonance is more
consistent with the mitochondrial NAD(P)H pool. Thus, the
metabolite content represented by the −10.4 ppm to −11.3 ppm
integral, which includes the unique resonance at −11.05 ppm,
is in reasonable agreement with the total NAD(P) content
reported from biochemical analysis of vastus lateralis muscle
tissue.
Increase in −11.05 ppm Peak and
Mitochondrial Volume with Exercise
Training
Our second test of the nature of the unique resonance
took advantage of the increased mitochondrial content
that accompanied a 6-mo exercise training program in
these subjects (Jubrias et al., 2001). We tested whether
the −11.05 ppm resonance increased in proportion to the
elevation in mitochondrial volume density found with resistance
training (RT) in these subjects (131%). Figure 2 shows the
significant changes in the −11.05 ppm resonance with RT in
elderly subjects (139%), while no change was found on average
in either property in control (CN) or endurance trained (ET)
groups. Also, no change was found in the NADH peak area
at −10.60 ppm in the RT group (0.1 ± 0.5% ATP). Thus, the
adaptation in the −11.05 ppm peak was exclusively associated
with that of mitochondrial volume density with exercise training.
FIGURE 2 | Changes in NAD(P) resonances and mitochondrial volume
in control (CN), resistance trained (RT, blue), and endurance trained
(ET, red) groups. Change with exercise training in (A) the −11.05 ppm peak
area, and (B) mitochondrial volume density. *− P < 0.05 post- vs. pre-training.
Reciprocal Change in −11.05ppm Peak vs.
NAD(P)+ with Elevated Oxidation
A third test involved an exercise and recovery bout designed
to alter the NAD(P) resonances by elevating oxidative
phosphorylation, as shown in Figure 3.
Figure 3A shows the changes in creatine phosphate (PCr),
a natural indicator of cell ATP use and re-synthesis, during an
exercise and recovery bout. Exercise consisted of a 2min muscle
stimulation period that increased ATP use resulting in depletion
of PCr level from the resting state (red line). The curvilinear
shape of the PCr breakdown curve indicates that activation
of ATP synthesis by mitochondria reduces the net breakdown
toward the end of the stimulation period. Once stimulation ends
and contractile ATP demand ceases, oxidative phosphorylation
predominates (blue line) and PCr is resynthesized to quickly
return to resting levels.
Figure 3B shows the 31P spectra of the NAD(P) region
taken from 10 subjects during these two periods. The spectrum
collected from resting muscle (black line) represents the low
oxidative phosphorylation condition. The spectrum collected
from muscle during stimulation is shown in by red lines (left
hand panels) and that collected during the recovery period of
elevated oxidative phosphorylation is shown by the blue lines
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FIGURE 3 | Spectral changes during stimulation and recovery from exercise. (A) Exercise elicits elevated ATP use (PCr decline, red line) and oxidative
phosphorylation (PCr re-synthesis, blue line). (B) Altered 31P Spectra in stimulation (red) and recovery from exercise (blue) vs. resting muscle (black). (C) Subtraction of
spectra region in resting (black) vs. stimulated muscle (red) and vs. recovering (blue) muscle reveals reciprocal changes in −10.75 ppm and in −11.05 ppm regions.
The dashed peaks represent the resonances for the chemical metabolites in solution: NADH (−10.6 ppm), NAD+ (−10.75 ppm), and NADP+ (10.83 ppm). (D)
Reciprocal changes in integrated areas of −10.75 ppm and −11.05 ppm regions.
(right hand panels). The solid arrows show the reciprocal changes
in the−10.75 ppm and in the−11.05 ppm region.
Figure 3C shows the net differences in these regions with
subtraction of these spectra. The change in the −10.75 ppm
region is outlined by several dashed peaks. These peaks represent
the resonances of the following chemical metabolites in solution:
NADH (−10.6 ppm), NAD+ (−10.75 ppm), and NADP+ (10.83
ppm). Note that the decline in the −10.75 ppm region with
stimulation (red arrows) is matched by an equal rise in
the −11.05 ppm region. The opposite changes are seen during
recovery from stimulation (blue line): the −11.75 ppm region
rises and the−11.05 ppm region declines.
Figure 3D shows the integration of the peak areas in the
difference spectra. Equal and opposite change in the −10.75
vs. −11.05 ppm region is confirmed by no significant difference
in a paired t-test of the absolute integrated areas of the two
regions in stimulation or recovery (P > 0.15 each). Such
reciprocal changes are expected for a trade-off of oxidized and
reduced forms of NAD(P)+. The correspondence of the dashed
peaks representing the resonances for NAD+ and NADP+ and
the change in the −10.75 ppm region is strong support that
this region represents net changes in NAD(P)+. Similarly, the
reciprocal change in the−11.05 ppm region suggests that change
in NAD(P)H occurs in the region of the unique resonance. These
changes are consistent with the dynamics expected for reduction
and oxidation of mitochondrial NAD(P)H. Taken together, these
results point to mitochondrial NAD(P)H dynamics occurring at
the downfield spectral position (−11.05 ppm) from the resonance
defined by the chemical NADH (−10.6 ppm) that likely defines
the cell NADH.
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Exercise Training Accelerates NAD(P)
Dynamics and Phosphorylation
Our final test was whether the −11.06 ppm peak changes
with an independent measure of oxidative phosphorylation.
These subjects showed increased phosphorylation capacity after
endurance (ET) and resistance (RT) training (Jubrias et al., 2001).
This capacity was measured during the stimulation-recovery
experiment shown in Figure 3, which was undertaken in each
subject and repeated after exercise training. Table 1 shows the
changes in the −11.05 ppm peak in the three groups in this
training experiment and reveals that both ET and RT groups
show a net decline in the −11.05 ppm peak after training. No
change is apparent in the control group. A corresponding net
rise that balances the decline in the −11.05 ppm peak area is
apparent in the −10.6 ppm peak (ET) or the −11.75 ppm peak
(RT) with training. This rise in the integrated peaks in the −10.5
to −10.9 ppm region vs. the −11.05 ppm region demonstrates
a net stoichiometry in the changes of the NAD(P) peaks with
training. This net decline in the −11.05 ppm region during
elevated oxidation following training further supports this
spectral region as representing the mitochondrial metabolites,
NAD(P)H.
Figure 4 shows that the significant decline in the −11.05
ppm region (−10.9 to −11.3 ppm) mirrored the net increase in
phosphorylation with training in these subjects. These reciprocal
changes suggest that the 1-11.05 ppm region reflects the greater
oxidation of NAD(P)H that is expected with the elevated
phosphorylation (1PCr) found after training. Together, these
results support that mitochondrial NADH oxidation in vivo is
represented by the decline in the unique resonance at −11.05
ppm in the NADP region. Further, these results indicate that
the −11.05 ppm peak is a sensitive indicator of the impact of
an intervention on improving mitochondrial oxidation in elderly
muscle.
DISCUSSION
The metabolic role and redox state of the NAD(P) metabolites
depend on their cellular location as illustrated in Figure 5.
NADH is a critical substrate for oxidative phosphorylation and
predominates over NAD+ in mitochondria. The opposite is true
for the oxidized cytosol in which enzyme equilibria linked to
the phosphorylation potential holds NAD(P)H content low and
NAD(P)+ high (Williamson et al., 1967; Stubbs et al., 1972).
Here we describe a unique resonance at −11.05 ppm in the
in vivo 31P MR spectrum that conforms with the properties
of mitochondrial NAD(P)H. This unique resonance has the
high chemical content and the dynamic changes with oxidative
phosphorylation that are expected for the NAD(P) redox state
in mitochondria. In contrast, a second peak identified by an
NADH chemical standard (at −10.6 ppm) is consistent with
the low metabolite content expected for cytosolic NADH. Three
results summarize the evidence that the −11.05 ppm peak is a
natural indicator of the content and dynamics of mitochondrial
NAD(P)H and thereby provides a intrinsic probe of oxidative
phosphorylation in vivo:
FIGURE 4 | Changes in the −11.05ppm peak (A) and phosphorylation
(B) with exercise training. Net decrease in the −11.05 peak and net
elevation in oxidative phosphorylation during recovery is shown in muscle after
resistance (RT) and endurance (ET) training vs. controls (CN). *P < 0.05.
TABLE 1 | Change in peak areas during the exercise recovery period in
post- vs. pre-trained muscle.
Group 1−10.60 ppm 1−10.75 ppm 1−11.05 ppm
CN 2.3 ± 6.3 −1.0± 0.5 −0.2± 1.3
RT 0.3 ± 0.7 1.5 ± 0.4* −1.7 ± 0.7*
ET 1.5 ± 0.6* 0.1 ± 1.4 −1.7 ± 0.6*
Units are % NAD per α–ATP peak for three resonances at distinct chemical shifts (ppm)
in the NADP region. Values are means ± SE. 1 defines post- vs. pre-training changes in
the integral of area of each resonance per integral of the α–ATP resonance.
The groups are: CN, control; RT, resistance training; ET, endurance training groups.
1−10.6, 1−10.75, and 1−11.05 are the chemical shifts (ppm) for the resonances
defined by external standards for the reduced (NADH) and oxidized (NAD(P)+ ) forms and
a third resonance not identified by external standards, respectively.
*Bold font, P < 0.05 post- vs. pre-training.
i) Quantitative agreement: A correspondence is found between
the chemical content represented by the −11.05 ppm peak
and the NAD(P)H level estimated from the mitochondrial
content of these muscles and their changes with exercise
training.
ii) Reciprocal dynamics with NAD(P)+: The equal and opposite
change in the −11.05 ppm peak vs. NAD+ with exercise
and recovery reflects the expected trade-off between reduced
(NAD(P)H) and oxidized (NAD(P)+) redox states in
mitochondria.
iii) Dynamics parallel phosphorylation: A net decline in the
−11.05 ppm peak mirrors the greater phosphorylation after
exercise training, which supports this unique resonance as
a sensitive natural indicator of changes in mitochondrial
NAD(P)H oxidation with an intervention.
NAD(P) In vivo vs. In vitro
Several lines of evidence indicate good agreement of the NAD(P)
metabolite levels determined in the 31PMR spectrum in vivo and
those reported in isolated human muscle by in vitro methods.
The metabolite content represented by the peaks in the NAD(P)
region (−10.5 to −11.3 ppm; 11% NAD/ATP) is in agreement
with biochemical assays of NAD in human vastus lateralis
(Sahlin, 1983; Henriksson et al., 1986). Chemical identification
of the peaks in this region reveals that NAD(P)+ accounts for
60% of the total peak area while only 5% of the total is accounted
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FIGURE 5 | Scheme illustrating the disparity of NAD(P) redox states
expected in the cytosolic vs. mitochondrial compartments.
for by the chemically defined NADH (−10.6 ppm). The chemical
content of the NAD(P)+ region (0.4mM) is consistent with
estimates for NAD+ derived from biochemical assays in young
muscle (0.5mM). The remaining 38% of the peak area of the
NAD(P) region is represented by a peak centered at−11.05 ppm.
Both the MR determination and that derived from independent
measures estimate a NAD(P)H content of∼0.26mM.
Two Resonances Reflect NAD(P)H In vivo
A large difference in peak areas is expected from in vitro results
if cytosolic vs. mitochondrial NAD(P)H can be distinguished in
the 31P MR spectrum (Williamson et al., 1967; Stubbs et al.,
1972). The chemical content represented by the −10.60 ppm
peak was low (5% of NAD(P) integral) relative to the unique
resonance at−11.05 ppm (38%) as expected for cytosolic NADH,
which is maintained at a low level by enzyme equilibria linked
to the phosphorylation potential (Williamson et al., 1967; Stubbs
et al., 1972). The larger chemical content of the −11.05 ppm
corresponds with the predominance of mitochondrial NAD(P)H
pool. This agreement of the size of two 31P MR resonances
with the expected NAD(P)H contents provides evidence that the
cytosolic vs. mitochondrial NADH pools can be distinguished
by MRS in vivo (Krebs and Veech, 1969; Stubbs et al., 1972).
Compartmentalization of NAD(P)H
The basis of the distinct spectral positions of NAD(P) is likely
due to the changes in physical properties when the metabolite
is located inside a compartment, such as in mitochondria. For
example, enhanced fluorescence efficiency occurs with NAD(P)H
inside mitochondria due to binding to complex I of the electron
transport chain (Blinova et al., 2008), which permits highlighting
mitochondrial NAD(P)H by optical spectroscopy and imaging.
A second example is the different chemical shift in the 31P
MR spectrum seen with phosphoryl compounds located inside
erythrocytes (Kirk and Kuchel, 1988a,c; Larkin et al., 2007).
Compounds related to NAD(P) show a 1−0.5 ppm CS in the
red blood cell, which is similar to the shift of the −11.05 ppm
vs. −10.6 ppm NAD(P)H peak in vivo in muscle (Kirk and
Kuchel, 1988a,c; Larkin et al., 2007). The mechanism for this
downfield CS in red cells is reported to be elevated hydrogen
bonding resulting from the high protein concentration of the
erythrocyte (predominantly hemoglobin content) (Kirk and
Kuchel, 1988b; Larkin et al., 2007). A high protein content is also
characteristic of mitochondria (Vinnakota and Bassingthwaighte,
2004). Thus, the segregation of phosphoryl compounds inside
a high protein environment provides a physical mechanism for
the downfield CS of the −11.05 ppm peak (reflecting NAD(P)H
in mitochondria) relative to NAD(P)H in the cell (−10.6 ppm)
in vivo.
Increase in −11.05 ppm Peak and
Mitochondrial Content with Exercise
Training
A test of the identity of the −11.05 ppm peak is provided
by the changes in the peaks of the NAD(P) region and in
mitochondrial properties with exercise training (Figure 2). A
shift in NAD(P) metabolite levels in correspondence with
changes in mitochondria have been reported in several tissues
with calorie restriction in mice in in vitro assays (Chen et al.,
2008). One mechanism for an NAD+ increase is a rise in
the enzyme responsible for NAD+ biosynthesis—NAMPT—that
accompanies calorie restriction and exercise training (Costford
et al., 2009). These adaptations in NADH and mitochondria were
not uniform across tissues in calorie restricted mice (Chen et al.,
2008). They also differed between training modes in the human
muscle (Figure 2). A higher −11.05 ppm peak (139%) was
found in proportion to the greater mitochondrial content with
RT (131%), but neither property changed significantly with ET
(Figure 2). In contrast to the −11.05 ppm peak, the chemically
defined NADH peak at −10.6 ppm did not change despite the
increased mitochondrial content in RT. This stability of the peak
at −10.6 ppm in the face of a large increase in mitochondrial
content is consistent with this resonance representing NAD(P)H
in the cytosol. In contrast, a mitochondrial origin for the
−11.05 ppm peak is supported by the unique rise of this
resonance with mitochondrial volume density after exercise
training.
Activating NAD(P)H Generation and
Oxidation
A functional test of the identity of the −11.05 ppm peak is
provided by the dynamics of the peaks in the NADP region with
exercise and recovery. These dynamics are elicited by a protocol
that activates increased energy use (as shown by PCr depletion
from the resting state) followed by a period of elevated oxidative
phosphorylation after exercise (as shown by restoration of PCr,
Figure 3A). The peaks in the NAD region change in concert with
these PCr dynamics during exercise and recovery (Figure 3B)
to reveal the trade-offs in the reduced vs. oxidized redox states
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of NAD(P) (Figure 3C) (Jobsis and Duffield, 1967; Wendt and
Chapman, 1976). Such trade-offs are evident from the changes in
the −11.05 ppm peak, which are matched by equal and opposite
changes in oxidized NAD(P) (Figure 3D). Similar changes are
apparent in optical fluorescence studies that indicate reduced
mitochondrial NAD(P)H with muscle stimulation and oxidized
NAD(P)H during elevated oxidative phosphorylation in recovery
(Jobsis and Duffield, 1967; Wendt and Chapman, 1976; Gandra
et al., 2012; Claflin et al., 2015). A rise in NAD(P)H generation
under intense exercise has also been found in glycolytic type II
fibers of human muscle in biochemical studies (Ren et al., 1988),
while reduced NADH is found during sustained exercise in the
oxidative, type I fibers of humans (Ren et al., 1988). Thus, the
functional dynamics of the−11.05 ppm peak parallel the changes
in mitochondrial NAD(P)H during exercise cycles reported
in independent studies. These reciprocal changes in spectral
regions are consistent with the −11.05 ppm peak representing
mitochondrial NAD(P)H.
Sensitive Index of Mitochondrial Oxidative
Improvements
An in vivo measure of mitochondrial NAD(P)H holds the
promise of providing a natural indicator of oxidation adaptations
with an intervention in human muscle. A test of the−11.05 ppm
peak as such an indicator is provided by the results of exercise
training that raised oxidative phosphorylation in these subjects
(Jubrias et al., 2001). Figure 4 shows a net drop in the −11.05
ppm resonance in an exercise bout after exercise training. This
net decline parallels the net increase in phosphorylation rate and
suggests that the −11.05 ppm peak reflects increased oxidation
of mitochondrial NADH in the trained subjects. Independent
findings of faster oxygen uptake after exercise training support
these results. Human muscle O2 uptake during recovery from
exercise is increased and the kinetics of whole-body oxygen
uptake is more rapid at the onset of exercise after training in
adult and elderly subjects (Zoladz et al., 2006; Murias et al.,
2010). The alternative is a higher ATP flux without increased
O2 uptake as a result of improvement in the coupling of
generating ATP per O2, which also occurs with exercise training
(Conley et al., 2013). A recent analysis concluded that both
mechanisms are activated: greater electron transport chain flux
and more efficient generation of ATP appeared to contribute
nearly equally to the phosphorylation improvements in these
subjects (Conley, 2016). The results in Figure 4 support this
independent analysis to demonstrate that elevated oxidation
is a part of the improvement in mitochondrial capacity to
generate ATP after training. These results indicate that the
dynamics of the −11.05 ppm peak captures the mitochondrial
oxidation improvements that underlie greater phosphorylation.
Importantly, both the oxidation and phosphorylation measures
come from the same 31P MR spectra collected in a single exercise
test in human muscle in vivo.
Limitations and Future Directions
The low chemical content of NAD(P) related metabolites
(<1mM) in vivo is a limitation to detecting this natural indicator
by 31P MRS. Measurements are possible at the low field strength
of 1.5T because of the trade-off with high B1 field homogeneity at
1.5T, which provides good resolution of the individual NAD(P)
peaks despite the low signal-to-noise. The large diameter coil
(9 cm) used in this study and large muscle mass of the quadriceps
group (∼1 kg) also helped to improve the signal for detecting
these low concentration metabolites. Nonetheless, the high
standard errors on some of the determinations may be due to
this combination of low chemical content and low MRI field
strength. However, two advances allow improved signal-to-noise
over that found in the study. The first advance is the higher field
strength (3T)MRIs that are now available inmostmedical centers
that focus on human metabolic research. A second advance is
the ability to decouple protons from phosphorus to increase the
signal-to-noise of the NAD(P) peaks. Decoupling is a method
derived from high-resolution MR spectroscopy that is now a
standard feature of 3T MRIs with multi-nuclear detection (e.g.,
31P MRS) capability. Thus, the availability of the higher 3T field
strength for human studies and the ability to further enhance
signal-to-noise with proton decoupling will make detecting of the
NAD(P) peaks and their dynamic changes with an intervention
possible for clinical research studies.
SUMMARY
Here we show that a unique resonance in the in vivo
31P spectrum provides a natural indicator of mitochondrial
oxidation and its improvement with treatment. This assignment
comes from the known compartmentalization of NADH
between the highly oxidized cell (−10.6 ppm) vs. more reduced
mitochondria (−11.05 ppm). A functional test that followed
NAD(P) dynamics during exercise and recovery cycles confirmed
that the −11.05 ppm peak reflected oxidation and reduction of
mitochondrial NAD(P)H. Finally, the greater −11.05 ppm peak
changes in the exercise test paralleled the faster phosphorylation
rate in these subjects after exercise training. This correspondence
provides further support that this unique resonance is a natural
indicator of mitochondrial oxidation. Thus, intrinsic probes
are present in the 31P MR spectrum that reveal the NAD(P)
redox disparity between mitochondria and cell and provide a
natural indicator of oxidative phosphorylation that is sensitive to
improvements in mitochondrial function with treatment.
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